Drug discovery and Development

The process of the design/discovery of drugs typically involves understanding the character of targets such as enzyme, cell, tissues, etc which related to the disease, setting up the concept of drug design, providing lead compounds (via traditional medicines, natural products, biological macromolecules, compound libraries, computational chemistry, etc.) and lead optimisation by means of analysing structure-activity-relationships. The current state of the chemical and biological sciences required for pharmaceutical development edict that 5,000–10,000 chemical compounds must undergo laboratory screening for each new drug approved for use in humans. Out of these chemical compounds that are screened, approximately 250 will enter preclinical testing, and 5 will enter clinical testing. The overall process from discovery to the marketing of a drug can take 10 to 15 years.

  • Track 1-1 Molecular Drug Design and Drug properties
  • Track 2-2 Computer-assisted Drug Design
  • Track 3-3 Drug Design & Development Therapy
  • Track 4-4 Expert Opinion on Drug Metabolism and Toxicology
  • Track 5-5 Drug Safety Databases
  • Track 6-6 Targeted Drug Delivery System

Related Conference of Pharmaceutical Sciences